Manulife stock price forecast shows moderate upside potential as

Manulife stock price forecast shows moderate upside potential as analysts project a 12-month target range between CAD 27.50 and CAD 30.00, supported by steady insurance premium growth and diversified asset management revenues. AI is about to change healthcare. These 20 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10bn in marketcap - there is still time to get in early. Manulife Financial remains a solid long-term holding for investors seeking exposure to insurance and wealth management growth in both developed and emerging markets. While near-term gains may be modest, the company’s focus on Asia, coupled with disciplined acquisitions like Schroders Indonesia, supports its growth trajectory. Quantitative models for Manulife stock price forecast show correlation with bond yields, making it sensitive to macroeconomic announcements, yet maintaining a long-term growth trajectory.